![[ Visit Client Website ]](images/banner.jpg)
Course
Indicates that handouts are availableThursday, February 27, 2014
7:20 AM-5:00 PM
0001
28th Annual Harold S. Nelson Military Allergy/Immunology Symposium TICKETED
Session Details
Learning Objectives:
Session Details
Thursday, February 27, 2014: 7:20 AM-5:00 PM
, ,
7.00 CME/ 8.00 CE
Moderator:
Kimberly S. Johnson , MD
- Discuss the approach to identifying allergic skin disorders in the military environment and the role of biopsy in the diagnosis and management
- Identify the differential diagnosis of chronic urticaria and explain the diagnostic approach
- Discuss the application of novel therapy in the treatment of chronic urticaria
Friday, February 28, 2014
7:00 AM-2:00 PM
1011
FIT Symposium TICKETED
Session Details
Learning Objectives:
Session Details
Friday, February 28, 2014: 7:00 AM-2:00 PM
Marriott North Tower, Lobby Level, San Diego Ballroom Salon B
0.00 CME/ 0.00 CE
Moderator:
Taylor A. Banks , MD
- Describe the pathophysiology, initial evaluation and management of patients with allergies to aeroallergens and/or venoms
- Identify recent advances in the field of immunotherapy, including mechanisms of immunomodulation
- Outline current and emerging treatment modalities and adjuncts in the management of aeroallergen and venom allergic patients
7:30 AM-2:00 PM
1111
2014 Chrysalis Project Program TICKETED
Session Details
Session Details
Friday, February 28, 2014: 7:30 AM-2:00 PM
Marriott North Tower, Lobby Level, Rancho Santa Fe 1 - 3
0.00 CME/ 0.00 CE
Learning Objectives:
- NA
8:15 AM-12:00 PM
1112
How to Develop and Maintain Excellence in Allergy/Immunology Fellowships: Boot Camp for Program Directors and Clinical Faculty TICKETED
Session Details
Learning Objectives:
Session Details
Friday, February 28, 2014: 8:15 AM-12:00 PM
Marriott North Tower, Lobby Level, San Diego Ballroom Salon A
0.00 CME/ 0.00 CE
Moderator:
Asriani M. Chiu , MD FAAAAI
- Provide practical tips for developing and enhancing an A/I fellowship program in the context of the “next accreditation system”
- Enhance the teaching skills of upcoming, new and current Allergy/Immunology fellowship Program Directors & Associate Program Directors, “core” A/I fellowship faculty, and community volunteer clinical faculty
- Support the development of Allergy/Immunology Program Directors, fellowship “core” faculty and community volunteer clinical faculty; Improve the quality of Allergy/Immunology fellowship training
9:00 AM-10:00 AM
1209
Allergen Immunotherapy: The Nuts and the Bolts (Part 1) TICKETED
Session Details
Learning Objectives:
Session Details
Friday, February 28, 2014: 9:00 AM-10:00 AM
Convention Center, , Room 30CDE
1.00 CME/ 1.20 CE
Moderator:
Matthew A. Rank , MD FAAAAI
- Discuss how diagnosis might improve with in vitro techniques to come
- Discuss clinical readiness of food immunotherapy
9:00 AM-12:00 PM
1201
Advanced Course in Pollen Identification TICKETED
Session Details
Learning Objectives:
Session Details
Friday, February 28, 2014: 9:00 AM-12:00 PM
Marriott North Tower, Lobby Level, Marriott Hall Salon 3
3.00 CME/ 3.60 CE
Moderator:
Estelle Levetin , PhD FAAAAI
- Differentiate pollen in the birch family and related tri-porate pollen types
- Recognize difficult tricolporate pollen types
- Differentiate asteraceae pollen other than ragweed
1202
NIAID: Epigenetics in Asthma and Allergy: Basic Concepts and Recent Advances
Session Details
Learning Objectives:
Session Details
Friday, February 28, 2014: 9:00 AM-12:00 PM
Convention Center, Upper Level, Room 11AB
2.75 CME/ 3.30 CE
Moderator:
Alkis Togias , MD FAAAAI
- Describe the importance of epigenetic changes and their potential impact on our understanding and treatment of allergic diseases and asthma
- Identify specific cells and pathways relevant to allergy and asthma where epigenetic changes may influence disease
1203
Technology in the Clinical Practice Made Ridiculously Simple
Session Details
Learning Objectives:
Session Details
Friday, February 28, 2014: 9:00 AM-12:00 PM
Convention Center, Mezzanine Level, Room 14AB
3.00 CME/ 3.40 CE
Moderator:
Tao T. Le , MD MHS FAAAAI
- Describe EHRs, practice management systems and office automation technologies appropriate for the clinical practice
- Explain the role of mobile technologies in the practice
- List web and social media tools for practice marketing and communications
1204
Endoscopic Evaluation and Management of Chronic Rhinosinusitis (Pre- and Post-Surgery) Including Cultures TICKETED
Session Details
Learning Objectives:
Session Details
Friday, February 28, 2014: 9:00 AM-12:00 PM
Convention Center, Upper Level, Room 3
3.00 CME/ 3.40 CE
Moderator:
Anju T. Peters , MD FAAAAI
- Describe the anatomy of the paranasal sinuses and identify pathology on CT scan
- Recall indications for surgery and complications of surgery
- Perform endoscopy in patients with CRS as well as cultures of the middle meatus and/or sinuses and review management of complicated sinusitis
1205
Difficult Cases (Part 1) TICKETED
Session Details
Learning Objectives:
Session Details
Friday, February 28, 2014: 9:00 AM-12:00 PM
Convention Center, Mezzanine Level, Room 15AB
2.75 CME/ 3.20 CE
Primary Moderators:
David W. Hauswirth , MD FAAAAI
Joyce E. Yu , MD
Joyce E. Yu , MD
- Discuss diagnostic and clinical management challenges encountered in Allergy, Asthma and Immunology practice
1206
Primary Immunodeficiency Diseases: What Do I Do with My Patient? From Start to Finish
Session Details
Learning Objectives:
Session Details
Friday, February 28, 2014: 9:00 AM-12:00 PM
Convention Center, Upper Level, Ballroom 6CF
2.75 CME/ 3.30 CE
Moderator:
Lisa J. Kobrynski , MD MPH FAAAAI
- Describe a general approach to a patient with recurrent infections or other presentation consistent with PID
- Discuss the stepwise approach to the diagnosis of PID and how to apply advanced and specialized tests, possibly in conjunction with guidance from a tertiary provider
- List the different modalities available for therapy, general principles of their application and resources for guidance in unusual or complex situations
1207
Drug Hypersensitivity
Session Details
Learning Objectives:
Session Details
Friday, February 28, 2014: 9:00 AM-12:00 PM
Convention Center, Upper Level, Ballroom 6DE
2.75 CME/ 3.30 CE
Moderator:
Rebecca S. Gruchalla , MD PhD FAAAAI
- List the symptoms of Type I drug hypersensitivity reactions
- Identify symptoms of Type IV drug hypersensitivity reactions
- Describe diagnostic tools for Type I and Type IV drug hypersensitivity reactions
1208
Dermatology for the Allergist: Diagnosis and Therapeutics Boot Camp TICKETED
Session Details
Learning Objectives:
Session Details
Friday, February 28, 2014: 9:00 AM-12:00 PM
Convention Center, Mezzanine Level, Room 16AB
3.00 CME/ 3.40 CE
Moderator:
Lynda C. Schneider , MD FAAAAI
- Discuss common diagnostic tests applicable to eczemas
- Outline basic skin care for allergic skin diseases and avoidance of pitfalls
1210
Principles of Healthy Homes: What to Look for and How to Help Your Patients or Evaluation and Mitigation TICKETED
Session Details
Learning Objectives:
Session Details
Friday, February 28, 2014: 9:00 AM-12:00 PM
Convention Center, Upper Level, Room 33C
2.75 CME/ 3.30 CE
Moderator:
Jay M. Portnoy , MD FAAAAI
- Identify the principles of healthy homes and the relative importance of each
- Identify the basic steps in taking an environmental history about a patient’s home environment
- Describe the essential steps to assess home environmental hazards and conditions and mitigation
10:00 AM-12:00 PM
1209AD
Hands-On Workshop: Allergy Skin Testing TICKETED
Session Details
Session Details
Friday, February 28, 2014: 10:00 AM-12:00 PM
Convention Center, Upper Level, Room 32AB
1.00 CME/ 1.20 CE
Learning Objectives:
- Compare the different devices and other equipment and their characteristics
- Explain the importance of standardized allergen extracts for the test result
- Demonstrate the importance of standardized testing technique and its control by proficiency testing
1209BC
Coding and Regulatory Issues Related to Allergy Diagnosis and Treatment TICKETED
Session Details
Session Details
Friday, February 28, 2014: 10:00 AM-12:00 PM
Convention Center, Upper Level, Room 33AB
1.00 CME/ 1.20 CE
Learning Objectives:
- Apply adequately the coding, documentation and regulatory guidelines for immunotherapy
2:00 PM-3:00 PM
1609
Allergen Immunotherapy: The Nuts and the Bolts (Part 2) TICKETED
Session Details
Learning Objectives:
Session Details
Friday, February 28, 2014: 2:00 PM-3:00 PM
Convention Center, , Room 30CDE
1.00 CME/ 1.20 CE
Moderator:
Michael R. Nelson , MD PhD FAAAAI
- Describe how immunotherapy can easily be dosed and the knowledge gaps we still have in this field
- Discuss when doses might be adjust for SCIT and for SLIT
2:00 PM-5:00 PM
1601
Advanced Course in Fungal Spore Identification TICKETED
Session Details
Learning Objectives:
Session Details
Friday, February 28, 2014: 2:00 PM-5:00 PM
Marriott North Tower, Lobby Level, Marriott Hall Salon 3
3.00 CME/ 3.60 CE
Moderator:
Estelle Levetin , PhD FAAAAI
- Interpret common basidiospores
- Interpret common ascospores
- Describe Fusarium, Penicillium/Aspergillus and other difficult spore types
1602
NIAID: Recent Advances in Biomarkers of Allergy and Asthma
Session Details
Learning Objectives:
Session Details
Friday, February 28, 2014: 2:00 PM-5:00 PM
Convention Center, Upper Level, Room 11AB
2.75 CME/ 3.30 CE
Moderator:
Marshall Plaut , MD FAAAAI
- Explain how mediators produced following allergen challenge predict the status of allergic diseases
- Describe the relationship of successful allergen immunotherapy to effects on circulating T cell subsets and antibody responses
- Appreciate the value of measuring peripheral blood basophil activation in allergic diseases and asthma
1603
Finding a Job and Getting Started in Practice
Session Details
Learning Objectives:
Session Details
Friday, February 28, 2014: 2:00 PM-5:00 PM
Convention Center, Upper Level, Room 2
3.00 CME/ 3.40 CE
Moderator:
Tao T. Le , MD MHS FAAAAI
- Outline how to identify and join the right practice opportunity
- Discuss the fundamentals of office management
- Identify strategies for marketing a practice and building a patient base
1604
Difficult Cases (Part 2) TICKETED
Session Details
Learning Objectives:
Session Details
Friday, February 28, 2014: 2:00 PM-5:00 PM
Convention Center, Mezzanine Level, Room 15AB
2.75 CME/ 3.20 CE
Primary Moderators:
Jason W. Caldwell , DO FAAAAI
Michael H. Land , MD FAAAAI
Michael H. Land , MD FAAAAI
- Discuss diagnostic and clinical management challenges encountered in Allergy, Asthma and Immunology practice
1605
Mast Cell Activation Syndromes: From Anaphylaxis to Mastocytosis
Session Details
Learning Objectives:
Session Details
Friday, February 28, 2014: 2:00 PM-5:00 PM
Convention Center, Upper Level, Ballroom 6A
2.75 CME/ 3.30 CE
Moderator:
Luis Escribano , MD PhD FAAAAI
- Discuss the symptoms and presentation of mast cell activation syndromes (MCAS)
- Outline the role of tryptase and c-kit mutations in MCAS
- Describe management options for MCAS
1606
Review of Systemic Autoimmune Disease and Treatment
Session Details
Learning Objectives:
Session Details
Friday, February 28, 2014: 2:00 PM-5:00 PM
Convention Center, Upper Level, Ballroom 6B
3.00 CME/ 3.60 CE
Moderator:
Arnold I. Levinson , MD FAAAAI
- Interpret screening and follow-up reflex testing in the diagnosis of autoimmune disease
- Review the latest treatment guidelines for rheumatoid arthritis
- Describe the organ systems lupus can affect and the downstream sequelae of complement activation
1607
Primary Immune Deficiency: A Global Perspective
Session Details
Learning Objectives:
Session Details
Friday, February 28, 2014: 2:00 PM-5:00 PM
Convention Center, Upper Level, Ballroom 6CF
3.00 CME/ 3.40 CE
Primary Moderators:
Motohiro Ebisawa , MD PhD FAAAAI
Elham M. Hossny , MD PhD FAAAAI
Mona I. Kidon , MD FAAAAI
Elham M. Hossny , MD PhD FAAAAI
Mona I. Kidon , MD FAAAAI
- Discuss ethnic and geographical differences in PID prevalence and clinical presentation around the world
- Discuss international vaccine programs and challenges posed for the PID community
- Review clinical scenarios of PID management in different settings around the world
1608
NIEHS: Exposure to Indoor Allergens and Endotoxin in Relation to Allergic Disease: Results from NHANES 2005-2006
Session Details
Learning Objectives:
Session Details
Friday, February 28, 2014: 2:00 PM-5:00 PM
Convention Center, Upper Level, Ballroom 6DE
2.75 CME/ 3.20 CE
Primary Moderators:
Paivi M. Salo , PhD
Darryl C. Zeldin , MD
Darryl C. Zeldin , MD
- Interpret the role that allergen/endotoxin exposures and allergic sensitization play in allergic diseases
- Apply new, standardized methods in indoor allergen assessment
- Review strategic objectives of NHANES and the allergy component
1610
Personalized Medicine Approaches in Asthma and Allergy
Session Details
Learning Objectives:
Session Details
Friday, February 28, 2014: 2:00 PM-5:00 PM
Convention Center, Upper Level, Room 8
2.75 CME/ 3.20 CE
Moderator:
Antonella Cianferoni , MD PhD
- Discuss the availability for genetic variation in disease risk, progression and therapy
- Describe readily available predictive tests (genetic and non-genetic)
- Describe the use and cost effectiveness of a personalized medicine approach in clinical practice
1611
Career Building for the Junior Investigator
Session Details
Learning Objectives:
Session Details
Friday, February 28, 2014: 2:00 PM-5:00 PM
Convention Center, Upper Level, Room 1AB
2.75 CME/ 3.20 CE
Moderator:
Laura B. Fanning , MD
- Discuss how to develop a specific clinical and scientific expertise
- Discuss how to manage their time effectively and how to choose roles and projects wisely
- Describe benchmarks of success
1612
Hands-On Rhinolaryngoscopy TICKETED
Session Details
Learning Objectives:
Session Details
Friday, February 28, 2014: 2:00 PM-5:00 PM
Convention Center, Upper Level, Room 30AB
2.75 CME/ 3.30 CE
Moderator:
Jerald W. Koepke , MD FAAAAI
- Describe the surgical anatomy of the upper airway, including the nasal cavity, pharynx and larynx
- Identify examples of normal and abnormal anatomy, as well as disease presentations and post-operative changes found with endoscopic examination of the upper airway
- Identify indications for and the use of the fiberoptic rhinoscope in the allergist’s office
1613
Interpretation of Pulmonary Function Tests (PFTs) TICKETED
Session Details
Learning Objectives:
Session Details
Friday, February 28, 2014: 2:00 PM-5:00 PM
Convention Center, Upper Level, Room 33C
3.00 CME/ 3.50 CE
Moderator:
Mark F. Sands , MD FAAAAI
- Describe the components of pulmonary function testing
- Recognize simple and complex obstructive and restrictive pulmonary abnormalities
- Interpret PFTs from asthma and COPD to fixed and variable obstructive abnormalities, as well as interstitial and other restrictive diseases
3:00 PM-5:00 PM
1609AD
Hands-On Workshop: Media Fill Test and Extract Preparation Management TICKETED
Session Details
Session Details
Friday, February 28, 2014: 3:00 PM-5:00 PM
Convention Center, Upper Level, Room 32AB
1.00 CME/ 1.20 CE
Learning Objectives:
- Demonstrate the ability to make a sterile immunotherapy vial
1609BC
Allergen Immunotherapy Prescription Writing: Cross-Reactivity, Proteolytic Enzymes, Diluents and Other Factors TICKETED
Session Details
Session Details
Friday, February 28, 2014: 3:00 PM-5:00 PM
Convention Center, Upper Level, Room 33AB
1.00 CME/ 1.20 CE
Learning Objectives:
- Demonstrate the proper method for writing immunotherapy prescriptions for optimal efficacy and safety
Saturday, March 1, 2014
2:00 PM-3:15 PM
2625
Allied Health Workshop: Travel Scholarship Award Recipients
Session Details
Learning Objectives:
Session Details
Saturday, March 1, 2014: 2:00 PM-3:15 PM
Marriott North Tower, Lobby Level, Atlanta
1.25 CME/ 1.50 CE
Moderator:
Stephen J. McGeady , MD FAAAAI
- Identify effective patient care strategies that can be implemented into the allergy/immunology practice
- Develop an appreciation for the activities of Allied Health members that contribute to the care of patients
- Develop professional networks within Allied Health
Tuesday, March 4, 2014
10:45 AM-1:45 PM
5311
Mechanisms of Allergic Inflammation TICKETED
Session Details
Learning Objectives:
Session Details
Tuesday, March 4, 2014: 10:45 AM-1:45 PM
Convention Center, Upper Level, Room 4
2.75 CME/ 3.20 CE
Moderator:
Mitchell H. Grayson , MD FAAAAI
- Describe mechanisms through which t-bet is able to suppress Th2 responses and discuss how dendritic cells and B cells drive Th2 development outside of the T cell zone
- Review how a viral respiratory infection can induce Th2 cytokine production from regulatory T cells
- Discuss how macromolecules can disrupt IgE-FcεRI complexes and how IgE interacts with CD23 and how this prevents binding to FcεRI and vice versa
5312
Developing Clinical Skills to Promote Adherence and Maximize Asthma Outcomes TICKETED
Session Details
Learning Objectives:
Session Details
Tuesday, March 4, 2014: 10:45 AM-1:45 PM
Convention Center, Upper Level, Room 3
2.75 CME/ 3.30 CE
Moderator:
Marcus S. Shaker , MD MS FAAAAI
- List objective means to diagnose adherence status
- Identify the reasons why patients are non-adherent with health care providers' plans
- Demonstrate motivational interviewing and other patient-centered techniques to help patients and families follow asthma treatment plans
5313
Mechanisms and Treatment of Exacerbations of Asthma TICKETED
Session Details
Learning Objectives:
Session Details
Tuesday, March 4, 2014: 10:45 AM-1:45 PM
Convention Center, Upper Level, Room 1AB
2.75 CME/ 3.30 CE
Primary Moderators:
James E. Gern , MD FAAAAI
Daniel J. Jackson , MD
Daniel J. Jackson , MD
- List the most common viruses and bacteria associated with asthma exacerbations
- Discuss mechanisms of virus-allergen interactions that promote exacerbations
- List major risk factors for exacerbations of asthma
5314
Owning the Bone: How to Minimize Glucocorticoid-Induced Osteoporosis Risk TICKETED
Session Details
Learning Objectives:
Session Details
Tuesday, March 4, 2014: 10:45 AM-1:45 PM
Convention Center, Upper Level, Room 8
2.75 CME/ 3.30 CE
Moderator:
Joshua A. Steinberg , MD
- Identify known bone health risks of acute and chronic exposure to inhaled and oral glucocorticoids
- Recognize differences between GIOP and post-menopausal osteoporosis pathophysiology, risk factors and screening tools
- Discuss present and emerging guidelines and pharmacotherapy in the prevention and management of GIOP